Inactive Instrument

News APTINYX

Stocks

APTX

US03836N1037

All News

23-12-18	Aptinyx Inc. Approves Liquidating Cash Distribution, Payable on or About December 29, 2023	CI
23-07-03	Aptinyx Inc. Announces Chief Executive Officer Changes	CI
23-07-03	Aptinyx Inc. Announces Management Changes	CI
23-07-03	Aptinyx Inc. Announces Principal Financial Officer Changes	CI
23-05-23	Aptinyx Inc. is Heading Towards Bankruptcy	CI
23-05-23	Aptinyx Inc.(OTCPK:APTX) dropped from S&P TMI Index	CI
23-05-18	Aptinyx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-05-18	Aptinyx Inc.(OTCPK:APTX) dropped from NASDAQ Composite Index	CI
23-05-11	APTINYX INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
23-05-05	APTINYX INC. : Other Events, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
23-05-05	Aptinyx Inc. Announces Executive Changes	CI
23-05-05	Aptinyx Inc. Announces Departure of Ashish Khanna as Chief Financial Officer	CI
23-05-05	Aptinyx Inc. Announces Departure of Andy Kidd, Chief Executive Officer	CI
23-04-25	APTINYX INC. : Termination of a Material Definitive Agreement (form 8-K)	AQ
23-04-18	APTINYX INC. : Change in Directors or Principal Officers (form 8-K)	AQ
23-03-30	APTINYX INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
23-03-30	Aptinyx Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-03-30	Aptinyx Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	CI
23-03-30	Aptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic Alternatives	BU
23-03-30	Henry Gosebruch, Former AbbVie EVP and Chief Strategy Officer, Joins ACELYRIN, INC. Board of Directors	AQ
23-03-29	Aptinyx Inc. Auditor Raises 'Going Concern' Doubt	CI
23-03-07	HC Wainwright Downgrades Aptinyx to Neutral From Buy	MT
23-03-01	SVB Securities Downgrades Aptinyx to Market Perform From Outperform, Price Target is $0.50	MT
23-03-01	Aptinyx : Costs Associated with Exit/Disposal - Form 8-K	PU
23-03-01	APTINYX INC. : Costs Associated with Exit or Disposal Activities (form 8-K)	AQ